Price Comparisons
Compare 5-Amino-1MQ Prices Find the best deals from trusted vendors Compare AOD-9604 Prices Compare Tesamorelin Prices Compare Tesofensine Prices Compare Tirzepatide Prices Compare Retatrutide Prices Compare S…
Approved comparison material connected to this topic.
11 total recordsSource comparisons are presented without a generated winner.
Compare 5-Amino-1MQ Prices Find the best deals from trusted vendors Compare AOD-9604 Prices Compare Tesamorelin Prices Compare Tesofensine Prices Compare Tirzepatide Prices Compare Retatrutide Prices Compare S…
GLP-4 vs GLP-5: Bioglutide vs VRX-0075 Bioglutide (GLP-4) adds muscle-sparing IGF-1 and has oral human data; VRX-0075 (GLP-5) adds amylin for deeper loss but is rat-only. Full comparison. Bioglutide vs Retatru…
Retatrutide vs Semaglutide: Triple vs Single Agonist Phase 2 trials reported 24.2% weight loss for retatrutide vs 14.9% for semaglutide in STEP 1 — but only one is FDA-approved. Full side-by-side. Liraglutide …
CJC-1295 + Ipamorelin GH secretagogue (GHRH + ghrelin mimetic) 11.4% visceral fat reduction over 16 weeks Preserved or increased (+1.2kg mean) Subcutaneous, 5 days/week 100mcg each before bed or fasted trainin…
Researchers selecting peptides for fat loss studies must match compound mechanism to experimental endpoints—GLP-1 agonists for appetite and gastric studies, GH secretagogues for lipolysis and body composition,…
AOD-9604 Direct lipolysis signalling Adipocyte mobilisation Selective fat mobilisation Tesamorelin GHRH-mediated GH elevation Visceral fat reduction Metabolic dysfunction CJC-1295 + Ipamorelin Sustained GH ele…
CJC-1295 + Ipamorelin GHRH receptor + ghrelin receptor dual agonism. Increases both GH pulse amplitude and frequency Pre-sleep (10–11 PM) or fasted morning (6–7 AM) 8.2–11.7% reduction vs baseline Gold standar…
Researchers searching for the best peptides for fat loss often have different goals than those searching for “weight loss peptides.” Fat loss implies body composition change — reducing adipose tissue while pot…
Retatrutide Triple GIP/GLP-1/glucagon agonist Up to 24.2% weight loss (Phase 2, 48 weeks) $39.99-$119.99 Tirzepatide Dual GIP/GLP-1 agonist Up to 20.9% weight loss (SURMOUNT-1, 72 weeks) $54.99-$104.99 AOD-960…
Semaglutide (GLP-1 receptor agonist) Chronic weight management; roughly 10–15% body-weight reduction vs placebo in obesity RCTs Strong human RCT — approved medicine (marketed as Wegovy) Prescription drug; GI s…
The table below compares the best peptides for fat loss across mechanism, clinical evidence, typical dosing, and practical limitations. Each peptide targets a different physiological pathway. Selecting the rig…